Kardigan, Inc. (KARD) Stock

Healthcare · Biotechnology · Member of Other US Stocks

Kardigan, Inc. (KARD) closed at USD 13.52 on 2026-10-14, a change of -38.5 % over the past year, with a market capitalization of USD 1.3B.

Kardigan, Inc. recent closing prices

DateClose (USD)
2026-10-1413.52
2026-10-1312.97
2026-10-1214.35
2026-10-0914.67
2026-10-0814.20
2026-10-0713.83
2026-10-0613.49

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Kardigan, Inc. key figures

Previous close
USD 13.52 (2026-10-14)
1-year change
-38.5 %
Market cap
USD 1.3B
Enterprise value
USD 713.58M
P/E ratio (trailing)
-1.22
P/E ratio (forward)
-4.77
EPS (trailing)
-11.40
EPS (forward)
-2.91
PEG ratio
n/a
Price to book
2.11
Revenue growth
n/a
Earnings growth
n/a
Dividend per share (trailing)
0.00
Short ratio
5.62
Employees
241
Analyst consensus (third-party)
strong_buy

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Kardigan, Inc.

Kardigan, Inc. operates as a biopharmaceutical company focused on developing medicines for cardiovascular diseases. The company develops and provides a portfolio of medicines that target the underlying pathophysiology of cardiovascular diseases, including primary and secondary cardiomyopathies leading to heart failure. It utilizes a proprietary research and development platform that integrates AI-based tools, real-world clinical data, and cardiac-specific analytics to optimize clinical study design, patient screening, and efficacy tracking. The company incorporates Prolaio's cardiovascular data collection and analytics platform, which includes FDA-cleared algorithms and high-density patient data, to support drug development and clinical intelligence. The company engages in strategic in-licensing and acquisitions to expand its pipeline of targeted treatments. Kardigan serves biopharmaceutical companies, cardiovascular researchers, and healthcare providers in the cardiology sector. The company was formerly known as EnCarda, Inc. and changed its name to Kardigan, Inc. in December 2024. The company was founded in 2023 and is based in Princeton, New Jersey.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Kardigan, Inc. and compare it with other stocks.

Analyze KARDAll Other US Stocks stocks

Stock-scoring.com provides this page for information only. It is not investment advice or a recommendation to buy or sell Kardigan, Inc. shares.